Skip to search formSkip to main contentSkip to account menu

Thymoglobulin

Known as: thymoglobuline 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (6)

Antilymphocyte ImmunoglobulinAntilymphocyte SerumImmunologic FactorsImmunosuppressive Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Induction Immunosuppression With Thymoglobulin and Rituximab in Intestinal and Multivisceral Transplantation
Background. Induction immunosuppression is now a common practice after intestinal and multivisceral transplantation. We report… 
2008
2008
CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A.
BACKGROUND Cytomegalovirus (CMV) infection is a major complication after renal transplantation and is involved in graft rejection… 
Review
2007
Review
2007
Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation.
Since the beginning of organ transplantation, graft preservation has been one of the most important concerns. Ischemia… 
2006
2006
The presence of B-cell nodules does not necessarily portend a less favorable outcome to therapy in patients with acute cellular rejection of a renal allograft.
2005
2005
Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients.
2005
2005
Highly successful living donor kidney transplantation after conversion to negative of a previously positive flow-cytometry cross-match by pretransplant plasmapheresis.
Review
2004
Review
2004
Five-Year Follow Up of Thymoglobulin Versus ATGAM Induction in Adult Renal Transplantation
Background. One-year results of a randomized, double-blinded trial of Thymoglobulin versus Atgam for induction therapy in renal… 
Review
2004
Review
2004
Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
Highly Cited
2003
Highly Cited
2003
Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation.
Highly Cited
2003
Highly Cited
2003
A pilot protocol of a calcineurin‐inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function
Abstract: Background: The worsening shortage of cadaver donor kidneys has prompted use of expanded or marginal donor kidneys (MDK… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)